Carmine Stolfi Selected Research

interleukin-21 (interleukin 21)

4/2015	Interleukin-21 sustains inflammatory signals that contribute to sporadic colon tumorigenesis.
12/2013	Role of TH17 cytokines in the control of colorectal cancer.
5/2012	Interleukin-21 in cancer immunotherapy: Friend or foe?
10/2011	Involvement of interleukin-21 in the regulation of colitis-associated colon cancer.
5/2011	IL-21 promotes skin recruitment of CD4(+) cells and drives IFN-γ-dependent epidermal hyperplasia.
8/2010	Interferon-gamma-expressing cells are a major source of interleukin-21 in inflammatory bowel diseases.
9/2009	Involvement of interleukin-21 in the epidermal hyperplasia of psoriasis.
4/2008	Regulation of gut inflammation and th17 cell response by interleukin-21.
2/2008	Autocrine regulation of IL-21 production in human T lymphocytes.
1/2007	A functional role for interleukin-21 in promoting the synthesis of the T-cell chemoattractant, MIP-3alpha, by gut epithelial cells.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.

Realize the full power of the drug-disease research graph!

Carmine Stolfi Research Topics

Disease

25	Neoplasms (Cancer) 10/2021 - 06/2008
16	Colorectal Neoplasms (Colorectal Cancer) 05/2021 - 02/2008
16	Inflammation (Inflammations) 12/2020 - 01/2007
14	Colitis 01/2022 - 04/2008
13	Inflammatory Bowel Diseases (Inflammatory Bowel Disease) 01/2022 - 01/2007
11	Crohn Disease (Crohn's Disease) 01/2022 - 02/2008
10	Colonic Neoplasms (Colon Cancer) 01/2021 - 02/2008
9	Carcinogenesis 01/2021 - 11/2008
6	Ulcerative Colitis 01/2022 - 08/2010
5	Colitis-Associated Neoplasms 01/2018 - 10/2011
3	Psoriasis (Pustulosis Palmaris et Plantaris) 01/2020 - 09/2009
2	Neoplastic Processes 01/2021 - 12/2013
2	Hyperplasia 05/2011 - 09/2009
1	Uterine Cervical Neoplasms (Cancer of the Cervix) 01/2021
1	Fibrosis (Cirrhosis) 12/2020
1	Infections 07/2020
1	Celiac Disease (Celiac Sprue) 06/2020
1	Multiple Myeloma 01/2020
1	Lung Neoplasms (Lung Cancer) 01/2020
1	Osteosarcoma (Osteogenic Sarcoma) 01/2020
1	Skin Neoplasms (Skin Cancer) 10/2019
1	Dysbiosis 10/2019
1	Type 2 Diabetes Mellitus (MODY) 01/2018
1	Adenoma (Adenomas) 10/2017
1	Neoplasm Metastasis (Metastasis) 05/2015

Drug/Important Bio-Agent (IBA)

21	CytokinesIBA 01/2022 - 01/2007
10	InterleukinsIBA 01/2020 - 01/2007
10	interleukin-21 (interleukin 21)IBA 04/2015 - 01/2007
8	Mesalamine (Mesalazine)FDA LinkGeneric 09/2013 - 02/2008
7	Pharmaceutical PreparationsIBA 07/2020 - 01/2010
7	Proteins (Proteins, Gene)FDA Link 05/2019 - 06/2008
6	Interleukin-17 (Interleukin 17)IBA 12/2013 - 02/2008
5	Transforming Growth Factor beta (TGF-beta)IBA 12/2020 - 11/2008
4	Tumor Necrosis Factor-alpha (Tumor Necrosis Factor)IBA 01/2022 - 01/2012
4	Antisense OligonucleotidesIBA 01/2022 - 01/2021
4	GED0301IBA 01/2022 - 07/2020
4	Dextran SulfateIBA 01/2019 - 04/2008
4	RNA (Ribonucleic Acid)IBA 07/2018 - 01/2013
3	AcidsIBA 01/2022 - 06/2009
3	Therapeutic UsesIBA 01/2020 - 01/2018
3	Calcibiotic Root Canal SealerIBA 10/2019 - 04/2015
3	Interleukin-6 (Interleukin 6)IBA 01/2018 - 10/2011
3	2-methoxy-5-amino-N-hydroxybenzamideIBA 09/2012 - 01/2010
2	DNA (Deoxyribonucleic Acid)IBA 10/2021 - 01/2021
2	Small Interfering RNA (siRNA)IBA 01/2021 - 01/2018
2	AntigensIBA 01/2021 - 01/2019
2	RafoxanideIBA 01/2020 - 10/2019
2	maltodextrinIBA 10/2019 - 01/2019
2	Transcription Factors (Transcription Factor)IBA 01/2019 - 01/2018
2	Interleukin-22 (IL-22)IBA 01/2019 - 12/2013
2	Transforming Growth Factors (Transforming Growth Factor)IBA 01/2018 - 11/2008
2	Interferon-gamma (Interferon, gamma)IBA 07/2014 - 08/2010
2	Interleukin-13IBA 03/2012 - 06/2009
2	TNF-Related Apoptosis-Inducing LigandIBA 01/2012 - 10/2011
2	AzoxymethaneIBA 10/2011 - 01/2010
1	Deubiquitinating EnzymesIBA 01/2022
1	Smad Proteins (Mothers Against Decapentaplegic Homolog)IBA 01/2022
1	APTIBA 10/2021
1	AGRO 100IBA 10/2021
1	NucleolinIBA 10/2021
1	Folate Receptor 1IBA 01/2021
1	Folic Acid (Vitamin M)FDA LinkGeneric 01/2021
1	Fragile X Mental Retardation ProteinIBA 01/2021
1	Doxorubicin (Adriamycin)FDA LinkGeneric 01/2021
1	Membrane Proteins (Integral Membrane Proteins)IBA 01/2021
1	Messenger RNA (mRNA)IBA 01/2021
1	Nucleic AcidsIBA 01/2021
1	MicroRNAs (MicroRNA)IBA 01/2021
1	OligonucleotidesIBA 07/2020
1	AnthelminticsIBA 07/2020
1	Glutens (Glutelin)IBA 06/2020
1	salicylhydroxamic acid (SHAM)IBA 01/2020
1	Albendazole (Albenza)FDA Link 01/2020
1	Mutant Proteins (Protein, Mutant)IBA 10/2019
1	Polysaccharides (Glycans)IBA 10/2019
1	Carboxymethylcellulose Sodium (Polycell)FDA Link 10/2019
1	Toll-Like Receptor 5IBA 10/2019
1	ProgranulinsIBA 10/2019
1	Polysorbates (PSML)FDA Link 10/2019
1	Interleukin-10 (Interleukin 10)IBA 10/2019
1	FlagellinIBA 10/2019
1	Dextrans (Dextran)FDA Link 05/2019
1	sodium sulfate (sodium bisulfate)FDA LinkGeneric 05/2019
1	6-formylindolo(3,2-b)carbazoleIBA 01/2019
1	ursodoxicoltaurineIBA 01/2019
1	Mucin-2IBA 01/2019
1	GelatinIBA 01/2019
1	Food Additives (Food Additive)IBA 01/2019
1	LigandsIBA 01/2019
1	Propylene Glycol (1,2 Propanediol)FDA LinkGeneric 01/2019
1	Follistatin-Related ProteinsIBA 07/2018
1	Hypoglycemic Agents (Hypoglycemics)IBA 01/2018
1	Metformin (Glucophage)FDA LinkGeneric 01/2018
1	p38 Mitogen-Activated Protein KinasesIBA 01/2018
1	AMP-Activated Protein KinasesIBA 01/2018
1	Protein Kinases (Protein Kinase)IBA 01/2017
1	Matrix Metalloproteinase 7 (Matrilysin)IBA 05/2015

Therapy/Procedure

8	Therapeutics 01/2022 - 10/2011
2	Chemoprevention 09/2013 - 01/2012
1	Drug Therapy (Chemotherapy) 01/2020